Printer Friendly

The bottom line.

The Bottom Line

Data from recent industry financial reports. Dollar amounts in
millions.

             Company                 Period   Ended    Sales     Chg.

Agilent Technologies (LSCA)            2Q     31-Mar   $344.0     3.3%
Barloworld (Scientific)               6 Mo    31-Mar   $124.4     5.7%
Beckman Coulter                        1Q     31-Mar   $576.1     7.3%
Beckman Coulter (Biomed. Rsch.)        1Q     31-Mar   $158.7     7.9%
BD (Biosciences)                       2Q     31-Mar   $204.1     8.5%
Bio-Rad Laboratories                   1Q     31-Mar   $299.2    13.9%
Bio-Rad Laboratories (Life             1Q     31-Mar   $144.1    18.5%
  Science)
Bruker BioSciences                     1Q     31-Mar    $74.9     9.9%
Bruker BioSciences (AXS)               1Q     31-Mar    $32.5    10.9%
Bruker BioSciences (Daltonics)         1Q     31-Mar    $42.6     9.8%
CEM                                    2Q     31-Mar    $26.4    13.0%
Ciphergen Biosystems                   1Q     31-Mar     $6.6   -49.8%
Harvard Bioscience                     1Q     31-Mar    $22.4     1.2%
Illumina                               1Q     31-Mar    $15.1    40.2%
Invitrogen                             1Q     31-Mar   $277.1    10.2%
Invitrogen (BioDiscovery)              1Q     31-Mar   $162.4     6.3%
Invitrogen (BioProduction)             1Q     31-Mar   $114.7    16.3%
Luminex                                1Q     31-Mar     $9.3     0.3%
Mettler-Toledo                         1Q     31-Mar   $337.2     5.8%
O.I. Corp.                             1Q     31-Mar     $7.7    20.4%
QIAGEN                                 1Q     31-Mar    $95.0    -1.1%
Roper Industries (Instrumentation)     1Q     31-Mar    $54.5    11.0%
Strategic Diagnostics                  1Q     31-Mar     $6.6     3.2%

                                      Op.               Net
             Company                 Prof.     Chg.    Prof.     Chg.

Agilent Technologies (LSCA)          $39.0      5.4%      N/A      N/A
Barloworld (Scientific)               $0.3    -89.3%      N/A      N/A
Beckman Coulter                      $75.8     12.0%   $41.4     16.3%
Beckman Coulter (Biomed. Rsch.)      $22.8     35.7%      N/A      N/A
BD (Biosciences)                        N/A      N/A      N/A      N/A
Bio-Rad Laboratories                 $40.1      5.8%   $33.5     52.4%
Bio-Rad Laboratories (Life           $15.5     -1.9%      N/A      N/A
  Science)
Bruker BioSciences                    $2.5     80.3%   $0.4     -12.4%
Bruker BioSciences (AXS)              $2.1    149.2%      N/A      N/A
Bruker BioSciences (Daltonics)        $4.3     36.6%      N/A      N/A
CEM                                   $3.9      7.0%      N/A      N/A
Ciphergen Biosystems                 ($8.8)       NM   ($9.3)       NM
Harvard Bioscience                    $0.5    210.4%   $0.2         NM
Illumina                             ($1.4)       NM   ($1.2)       NM
Invitrogen                           $43.8     71.7%   $47.1    347.9%
Invitrogen (BioDiscovery)            $45.0      3.7%      N/A      N/A
Invitrogen (BioProduction)           $26.9     28.1%      N/A      N/A
Luminex                              ($0.5)       NM   ($0.3)       NM
Mettler-Toledo                       $35.7      8.7%   $20.8    111.6%
O.I. Corp.                            $0.8     35.6%   $0.6      45.5%
QIAGEN                               $21.4     18.3%   $13.9     22.1%
Roper Industries (Instrumentation)   $10.8     14.7%      N/A      N/A
Strategic Diagnostics                 $0.6     -7.0%   $0.4       0.0%

NA = not available

NM = not meaningful
COPYRIGHT 2005 Strategic Directions International Inc. (SDI)
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Instrument Business Outlook
Article Type:Illustration
Date:May 15, 2005
Words:445
Previous Article:Market profile: near-field scanning microscopy.
Next Article:Agilent and SSI: a tsunami in the making.
Topics:


Related Articles
The bottom line.
The bottom line.
The bottom line.
The bottom line.
The bottom line.
The bottom line.
The bottom line.
The bottom line.
The bottom line.
The bottom line.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters